BROVANA Drug Patent Profile
✉ Email this page to a colleague
When do Brovana patents expire, and when can generic versions of Brovana launch?
Brovana is a drug marketed by Lupin and is included in one NDA.
The generic ingredient in BROVANA is arformoterol tartrate. There are four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the arformoterol tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brovana
A generic version of BROVANA was approved as arformoterol tartrate by CIPLA on June 22nd, 2021.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BROVANA?
- What are the global sales for BROVANA?
- What is Average Wholesale Price for BROVANA?
Summary for BROVANA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Clinical Trials: | 16 |
Patent Applications: | 117 |
Drug Prices: | Drug price information for BROVANA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for BROVANA |
What excipients (inactive ingredients) are in BROVANA? | BROVANA excipients list |
DailyMed Link: | BROVANA at DailyMed |
Recent Clinical Trials for BROVANA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Wake Forest University Health Sciences | Phase 4 |
Dartmouth-Hitchcock Medical Center | N/A |
Sunovion | N/A |
Pharmacology for BROVANA
Drug Class | beta2-Adrenergic Agonist |
Mechanism of Action | Adrenergic beta2-Agonists |
Paragraph IV (Patent) Challenges for BROVANA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
BROVANA | Inhalation Solution | arformoterol tartrate | Eq. 0.015 mg base/ 2 mL | 021912 | 1 | 2009-10-01 |
US Patents and Regulatory Information for BROVANA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin | BROVANA | arformoterol tartrate | SOLUTION;INHALATION | 021912-001 | Oct 6, 2006 | AN | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BROVANA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lupin | BROVANA | arformoterol tartrate | SOLUTION;INHALATION | 021912-001 | Oct 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Lupin | BROVANA | arformoterol tartrate | SOLUTION;INHALATION | 021912-001 | Oct 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Lupin | BROVANA | arformoterol tartrate | SOLUTION;INHALATION | 021912-001 | Oct 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Lupin | BROVANA | arformoterol tartrate | SOLUTION;INHALATION | 021912-001 | Oct 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BROVANA
See the table below for patents covering BROVANA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2004532217 | ⤷ Sign Up | |
Japan | 6214925 | ⤷ Sign Up | |
Spain | 2554476 | ⤷ Sign Up | |
European Patent Office | 1082293 | POLYMORPHES DU FORMOTEROL (FORMOTEROL POLYMORPHS) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |